The Role of High Mobility Group Box-1 in Epileptogenesis

被引：1
|
作者：
Fu, Li [1 ]
Nishibori, Masahiro [1 ]
机构：
[1] Okayama Univ, Dept Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan
来源：
ACTA MEDICA OKAYAMA | 2019年 / 73卷 / 05期
关键词：
HMGB1; epileptogenesis; inflammation; blood-brain barrier; TOLL-LIKE RECEPTOR; MONOCLONAL-ANTIBODY; HMGB1; EPILEPSY; PROTEIN; DYSFUNCTION; BIOMARKERS;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
High mobility group box-1 (HMGB1) is a non-histone, DNA-binding nuclear protein belonging to the family of damage-associated molecular patterns (DAMPs). HMGB1 has been reported to play an important role during epileptogenesis although the mechanisms of its actions are still not clear. Many hypotheses have been suggested especially about the relationship between HMGB1 and inflammation responses and blood-brain barrier disruption during epileptogenesis. In this review, we will mainly discuss the role of HMGB1 in epileptogenesis.
引用
收藏
页码：383 / 386
页数：4
相关论文
共 50 条
  • [1] Role of glycated high mobility group box-1 in gastric cancer
    Nishiguchi, Yukiko
    Kishi, Shingo
    Mori, Shiori
    Takagi, Tadataka
    Hojo, Yudai
    Sasaki, Takamitsu
    Fujii, Kiyomu
    Nakashima, Chie
    Lou, Yi
    Tani, Rina
    Kuniyasu, Hiroki
    CANCER SCIENCE, 2022, 113 : 447 - 447
  • [2] The role of high mobility group box-1 protein in severe sepsis
    Sunden-Cullberg, Jonas
    Norrby-Teglund, Anna
    Treutiger, Carl Johan
    CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (03) : 231 - 236
  • [3] High-mobility group box-1 and its role in angiogenesis
    Yang, Shuai
    Xu, Linxinyu
    Yang, Tianshu
    Wang, Fang
    JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 95 (04) : 563 - 574
  • [4] Role of High-Mobility Group Box-1 in Liver Pathogenesis
    Khambu, Bilon
    Yan, Shengmin
    Huda, Nazmul
    Yin, Xiao-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [5] Role of Glycated High Mobility Group Box-1 in Gastric Cancer
    Kishi, Shingo
    Nishiguchi, Yukiko
    Honoki, Kanya
    Mori, Shiori
    Fujiwara-Tani, Rina
    Sasaki, Takamitsu
    Fujii, Kiyomu
    Kawahara, Isao
    Goto, Kei
    Nakashima, Chie
    Kido, Akira
    Tanaka, Yasuhito
    Luo, Yi
    Kuniyasu, Hiroki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [6] Masquerader: High mobility group box-1 and cancer
    Ellerman, Jessica E.
    Brown, Charles K.
    de Vera, Michael
    Zeh, Herbert J.
    Billiar, Timothy
    Rubartelli, Anna
    Lotze, Michael T.
    CLINICAL CANCER RESEARCH, 2007, 13 (10) : 2836 - 2848
  • [7] High mobility group box-1 and cardiovascular diseases
    Ding, Hua-Sheng
    Yang, Jun
    SAUDI MEDICAL JOURNAL, 2010, 31 (05) : 486 - 489
  • [8] Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases
    Kumar, Vishal
    Kumar, Puneet
    INFLAMMOPHARMACOLOGY, 2025, 33 (02) : 703 - 727
  • [9] High-Mobility Group Box-1 and Liver Disease
    Gaskell, Harriet
    Ge, Xiaodong
    Nieto, Natalia
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (09) : 1005 - 1020
  • [10] The Role of High-Mobility Group Box-1 Protein in the Development of Diabetic Nephropathy
    Kim, Junghyun
    Sohn, Eunjin
    Kim, Chan-Sik
    Jo, Kyuhyung
    Kim, Jin Sook
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 33 (06) : 524 - 529
12345